+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Cardiology and Peripheral Vascular Devices Market By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 205 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640281
Description Jump to:
The global interventional cardiology and peripheral vascular devices market size was valued at $17,960.8 million in 2020, and is projected to reach $41,900.3 million by 2030, registering a CAGR of 8.5% from 2021 to 2030. Interventional cardiology is a branch of cardiology that focuses on treatment by using catheter-based technologies.

Interventional cardiology and peripheral vascular devices typically consist of balloons, catheters, guidewires, stents, and filters. These devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs.

The surge in number of patients suffering from various cardiovascular diseaseshas significantly increased owing to rise in geriatric population and changing lifestyle. This creates a demand for devices that can effectively treat various cardiovascular disorders, thereby, positively influencing the growth of the market. However, factors such as high treatment cost and stringent rules for approval of interventional cardiology and peripheral vascular devices can restraintthe market growth. Furthermore, rapid development of healthcare infrastructure in developing countries fueled by increased investment provides lucrative growth opportunities for the market.

The interventional cardiology and peripheral vascular devices market is segmented on the basis of product, end user, and region.By product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. By end user, it is segmented into hospitals, ambulatory surgical centers, and others. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players operating in the global market have adopted key strategies such as product launch to strengthen their market outreach and sustain the stiff competition in the market

Competition Analysis


The major market participants profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc. and Terumo Corporation.

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the current and emerging interventional cardiology and peripheral vascular devices market trends and dynamics.
  • In-depth market analysis is conducted by constructing market estimations for the key market segments between 2020 and 2030.
  • Extensive analysis of the interventional cardiology and peripheral vascular devices market is conducted by following key product positioning and monitoring of the top competitors within the market framework.
  • A comprehensive analysis of all regions is provided to determine the prevailing opportunities.
  • The global interventional cardiology and peripheral vascular devices market forecast analysis from 2021 to 2030 is included in the report.
  • The key market players within interventional cardiology and peripheral vascular devices market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the interventional cardiology and peripheral vascular devices industry.

Key Market Segments


By Type

  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Accessories
  • Angioplasty Balloons
  • Angioplasty Stents
  • Angioplasty Catheters
  • Endovascular Aneurysm Repair Stent Grafts

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest Of Asia Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Becton, Dickinson and Company.
  • Cardinal Health Inc.
  • Cook Group
  • Medtronic plc
  • Terumo Group
  • Koninklijke Philips N.V.
  • Biotronik SE & Co. KG

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Angioplasty Balloons
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Angioplasty Stents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Angioplasty Catheters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Endovascular Aneurysm Repair Stent Grafts
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Inferior Vena Cava (IVC) Filters
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Plaque Modification Devices
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Hemodynamic Flow Alteration Devices
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Accessories
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
CHAPTER 5: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ambulatory Surgical Centers
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Type
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Type
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Type
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Type
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Type
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Type
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Type
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Type
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Spain
6.3.4.4.1 Market size and forecast, by Type
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Type
6.3.4.5.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Type
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Type
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Type
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Type
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 Australia
6.4.4.4.1 Market size and forecast, by Type
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 Rest Of Asia Pacific
6.4.4.5.1 Market size and forecast, by Type
6.4.4.5.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Type
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Type
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Type
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Type
6.5.4.3.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 B. Braun Melsungen AG
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Becton, Dickinson and Company.
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Cardinal Health Inc.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Cook Group
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Medtronic plc
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Terumo Group
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Koninklijke Philips N.V.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Biotronik SE & Co. KG
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020-2030, ($Million)
Table 2. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Angioplasty Balloons, by Region, 2020-2030, ($Million)
Table 3. Interventional Cardiology and Peripheral Vascular Devices Market Angioplasty Balloons by Country, 2020-2030, ($Million)
Table 4. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Angioplasty Stents, by Region, 2020-2030, ($Million)
Table 5. Interventional Cardiology and Peripheral Vascular Devices Market Angioplasty Stents by Country, 2020-2030, ($Million)
Table 6. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Angioplasty Catheters, by Region, 2020-2030, ($Million)
Table 7. Interventional Cardiology and Peripheral Vascular Devices Market Angioplasty Catheters by Country, 2020-2030, ($Million)
Table 8. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Endovascular Aneurysm Repair Stent Grafts, by Region, 2020-2030, ($Million)
Table 9. Interventional Cardiology and Peripheral Vascular Devices Market Endovascular Aneurysm Repair Stent Grafts by Country, 2020-2030, ($Million)
Table 10. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Inferior Vena Cava (Ivc) Filters, by Region, 2020-2030, ($Million)
Table 11. Interventional Cardiology and Peripheral Vascular Devices Market Inferior Vena Cava (Ivc) Filters by Country, 2020-2030, ($Million)
Table 12. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Plaque Modification Devices, by Region, 2020-2030, ($Million)
Table 13. Interventional Cardiology and Peripheral Vascular Devices Market Plaque Modification Devices by Country, 2020-2030, ($Million)
Table 14. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Hemodynamic Flow Alteration Devices, by Region, 2020-2030, ($Million)
Table 15. Interventional Cardiology and Peripheral Vascular Devices Market Hemodynamic Flow Alteration Devices by Country, 2020-2030, ($Million)
Table 16. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Accessories, by Region, 2020-2030, ($Million)
Table 17. Interventional Cardiology and Peripheral Vascular Devices Market Accessories by Country, 2020-2030, ($Million)
Table 18. Global Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020-2030, ($Million)
Table 19. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Hospitals, by Region, 2020-2030, ($Million)
Table 20. Interventional Cardiology and Peripheral Vascular Devices Market Hospitals by Country, 2020-2030, ($Million)
Table 21. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Ambulatory Surgical Centers, by Region, 2020-2030, ($Million)
Table 22. Interventional Cardiology and Peripheral Vascular Devices Market Ambulatory Surgical Centers by Country, 2020-2030, ($Million)
Table 23. Interventional Cardiology and Peripheral Vascular Devices Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 24. Interventional Cardiology and Peripheral Vascular Devices Market Others by Country, 2020-2030, ($Million)
Table 25. Interventional Cardiology and Peripheral Vascular Devices Market, by Region, 2020-2030, ($Million)
Table 26. North America Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020-2030, ($Million)
Table 27. North America Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020-2030, ($Million)
Table 28. North America Interventional Cardiology and Peripheral Vascular Devices Market, by Country, 2020-2030, ($Million)
Table 29. U.S. Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 30. U.S. Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 31. Canada Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 32. Canada Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 33. Mexico Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 34. Mexico Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 35. Europe Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020-2030, ($Million)
Table 36. Europe Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020-2030, ($Million)
Table 37. Europe Interventional Cardiology and Peripheral Vascular Devices Market, by Country, 2020-2030, ($Million)
Table 38. Germany Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 39. Germany Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 40. France Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 41. France Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 42. U.K. Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 43. U.K. Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 44. Spain Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 45. Spain Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 46. Rest of Europe Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 47. Rest of Europe Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 48. Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020-2030, ($Million)
Table 49. Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020-2030, ($Million)
Table 50. Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market, by Country, 2020-2030, ($Million)
Table 51. China Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 52. China Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 53. Japan Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 54. Japan Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 55. India Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 56. India Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 57. Australia Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 58. Australia Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 59. Rest of Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 60. Rest of Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 61. LAMEA Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020-2030, ($Million)
Table 62. LAMEA Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020-2030, ($Million)
Table 63. LAMEA Interventional Cardiology and Peripheral Vascular Devices Market, by Country, 2020-2030, ($Million)
Table 64. Latin America Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 65. Latin America Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 66. Middle East Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 67. Middle East Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 68. Africa Interventional Cardiology and Peripheral Vascular Devices Market by Type 2020-2030, ($Million)
Table 69. Africa Interventional Cardiology and Peripheral Vascular Devices Market by End-user 2020-2030, ($Million)
Table 70. Abbott Laboratories: Company Snapshot
Table 71. Abbott Laboratories: Operating Segments
Table 72. Abbott Laboratories: Product Portfolio
Table 73. Abbott Laboratories: Net Sales
Table 74. Abbott Laboratories: Key Stratergies
Table 75. B. Braun Melsungen Ag: Company Snapshot
Table 76. B. Braun Melsungen Ag: Operating Segments
Table 77. B. Braun Melsungen Ag: Product Portfolio
Table 78. B. Braun Melsungen Ag: Net Sales
Table 79. B. Braun Melsungen Ag: Key Stratergies
Table 80. Boston Scientific Corporation: Company Snapshot
Table 81. Boston Scientific Corporation: Operating Segments
Table 82. Boston Scientific Corporation: Product Portfolio
Table 83. Boston Scientific Corporation: Net Sales
Table 84. Boston Scientific Corporation: Key Stratergies
Table 85. Becton, Dickinson and Company.: Company Snapshot
Table 86. Becton, Dickinson and Company.: Operating Segments
Table 87. Becton, Dickinson and Company.: Product Portfolio
Table 88. Becton, Dickinson and Company.: Net Sales
Table 89. Becton, Dickinson and Company.: Key Stratergies
Table 90. Cardinal Health Inc.: Company Snapshot
Table 91. Cardinal Health Inc.: Operating Segments
Table 92. Cardinal Health Inc.: Product Portfolio
Table 93. Cardinal Health Inc.: Net Sales
Table 94. Cardinal Health Inc.: Key Stratergies
Table 95. Cook Group: Company Snapshot
Table 96. Cook Group: Operating Segments
Table 97. Cook Group: Product Portfolio
Table 98. Cook Group: Net Sales
Table 99. Cook Group: Key Stratergies
Table 100. Medtronic plc: Company Snapshot
Table 101. Medtronic plc: Operating Segments
Table 102. Medtronic plc: Product Portfolio
Table 103. Medtronic plc: Net Sales
Table 104. Medtronic plc: Key Stratergies
Table 105. Terumo Group: Company Snapshot
Table 106. Terumo Group: Operating Segments
Table 107. Terumo Group: Product Portfolio
Table 108. Terumo Group: Net Sales
Table 109. Terumo Group: Key Stratergies
Table 110. Koninklijke Philips N.V.: Company Snapshot
Table 111. Koninklijke Philips N.V.: Operating Segments
Table 112. Koninklijke Philips N.V.: Product Portfolio
Table 113. Koninklijke Philips N.V.: Net Sales
Table 114. Koninklijke Philips N.V.: Key Stratergies
Table 115. Biotronik Se & Co. Kg: Company Snapshot
Table 116. Biotronik Se & Co. Kg: Operating Segments
Table 117. Biotronik Se & Co. Kg: Product Portfolio
Table 118. Biotronik Se & Co. Kg: Net Sales
Table 119. Biotronik Se & Co. Kg: Key Stratergies
LIST OF FIGURES
Figure 1. Interventional Cardiology and Peripheral Vascular Devices Market Segmentation
Figure 2. Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030
Figure 3. Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Interventional Cardiology and Peripheral Vascular Devices Market:Drivers, Restraints and Opportunities
Figure 11. Interventional Cardiology and Peripheral Vascular Devices Market, by Type, 2020 (%)
Figure 12. Comparative Share Analysis of Angioplasty Balloons Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Angioplasty Stents Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Angioplasty Catheters Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Endovascular Aneurysm Repair Stent Grafts Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Inferior Vena Cava (Ivc) Filters Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Plaque Modification Devices Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Hemodynamic Flow Alteration Devices Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Accessories Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 20. Interventional Cardiology and Peripheral Vascular Devices Market, by End-user, 2020 (%)
Figure 21. Comparative Share Analysis of Hospitals Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 22. Comparative Share Analysis of Ambulatory Surgical Centers Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of Others Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 (%)
Figure 24. Interventional Cardiology and Peripheral Vascular Devices Market by Region, 2020
Figure 25. U.S. Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 26. Canada Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 27. Mexico Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 28. Germany Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 29. France Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 30. U.K. Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 31. Spain Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 32. Rest of Europe Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 33. China Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 34. Japan Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 35. India Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 36. Australia Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 37. Rest of Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 38. Latin America Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 39. Middle East Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 40. Africa Interventional Cardiology and Peripheral Vascular Devices Market, 2020-2030 ($Million)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap of Top 10 Key Players
Figure 47. Abbott Laboratories.: Net Sales, ($Million)
Figure 48. B. Braun Melsungen AG.: Net Sales, ($Million)
Figure 49. Boston Scientific Corporation.: Net Sales, ($Million)
Figure 50. Becton, Dickinson and Company. Net Sales, ($Million)
Figure 51. Cardinal Health Inc. Net Sales, ($Million)
Figure 52. Cook Group.: Net Sales, ($Million)
Figure 53. Medtronic PLC.: Net Sales, ($Million)
Figure 54. Terumo Group.: Net Sales, ($Million)
Figure 55. Koninklijke Philips N.V. Net Sales, ($Million)
Figure 56. Biotronik SE & Co. KG.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Interventional Cardiology and Peripheral Vascular Devices Market,' the interventional cardiology and peripheral vascular devices market was valued at $18.0 billion in 2020, and is estimated to reach $41.9 billion by 2030, growing at a CAGR of 8.5% from 2021 to 2030.

By product the market is segmented into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Among these, the angioplasty balloons segment accounted for the highest market share in 2020 and accessories segment is expected to witness significant growth during the market forecast period owing to rise in number of patients suffering from chronic diseases. The market is analyzed with respect to different applications in industrial verticals such as hospitals, ambulatory surgical centers, and others. The interventional cardiology market is mainly driven by increase in number of patients suffering from cardiovascular diseases owing to rising geriatric population. However, factors such as high treatment cost and stringent approval procedure for interventional cardiology technology can restraint the growth of interventional cardiology market.

In 2020, North America dominated the global interventional cardiology and peripheral vascular devices market share, in terms of revenue, accounting for around 41% share of the interventional cardiology and peripheral vascular devices industry, followed by Europe and Asia-Pacific. Moreover, the market in Asia-Pacific is growing with high CAGR, owing to effectiveness of interventional cardiology and peripheral vascular devices in treatment of various cardiovascular diseases.

Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for the treatment of structural heart diseases. Catheterization is used for performing large number of procedures on the heart. It involves the insertion of a sheath into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). Thus, interventional cardiology and peripheral vascular devices are suitable for treatment for a wide range of cardiovascular ailments. Furthermore, increased number of patients suffering from chronic diseases, owing to rise in geriatric populations has driven the growth of the market. Also, growth of healthcare industry in emerging countries and advanced healthcare facilities in developed countries has propelled the interventional cardiology and peripheral vascular devices market size.

Furthermore, on the basis of end user, the ambulatory surgical centers is anticipated to grow rapidly, with a CAGR 9.3% during the interventional cardiology and peripheral vascular devices market forecast period owing to increase in demand for healthcare facility due to rise in geriatric population.

For instance, according to World Health Organization, the number of people aged 60 years and older was 1 billion in 2019, and is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050. Thus, the rise of geriatric population has increased the number of patients suffering from various chronic diseases, thereby positively influencing the market.

However, during the pandemic lockdown, various players in the interventional cardiology market reduced their business in countries such as China, the U.S., and India owing to disruption of supply chain. This break directly impactedcompanies involved in interventional cardiology and peripheral vascular device manufacturing. In addition, extensive focus of major countries on development of vaccineshas also negatively influenced the interventional cardiology market. However, reopening of research and manufacturingfacilities and introduction of vaccines for coronavirus disease are anticipated to boost the interventional cardiology and peripheral vascular devices industry.

The key players profiled in the interventional cardiology and peripheral vascular devices market report includeAbbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc. and Terumo Corporation.

Key findings of the Study

  • The report provides an extensive analysis of the current and emerging interventional cardiology and peripheral vascular devices market trends and dynamics.
  • Depending on product, the angioplasty balloons dominated the interventional cardiology and peripheral vascular devices market, in terms of revenue in 2020 and the accessories segment is projected to grow at a significant CAGR during the forecast period.
  • By end user, the hospitals segment registered highest revenue in 2020.
  • Asia-Pacific is projected to register highest growth rate in the coming years.
The key players within the interventional cardiology and peripheral vascular devices market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of theradiology information systemindustry.

The report provides an extensive analysis of thecurrent trends and emerging opportunities of the market.
In-depthinterventional cardiology and peripheral vascular devices market analysis is conducted by constructing estimations for the key segments between 2021 and 2030.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Becton, Dickinson and Company.
  • Cardinal Health Inc.
  • Cook Group
  • Medtronic plc
  • Terumo Group
  • Koninklijke Philips N.V.
  • Biotronik SE & Co. KG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages205
PublishedMarch 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 17960.8 million
Forecasted Market Value ( USD ) by 2030 $ 41900.3 million
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2024-2032 - Product Image

Global Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Global Interventional Cardiology Market Size, Share & COVID19 Impact Analysis 2023-2029 MedSuite Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more - Product Image

Global Interventional Cardiology Market Size, Share & COVID19 Impact Analysis 2023-2029 MedSuite Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more

  • Report
  • 577 Pages
  • Global
From
Interventional Cardiology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Interventional Cardiology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Global Interventional Cardiology Devices Market Analysis & Forecast 2024-2034: Market By Product; By End-user; and By Region - Product Image

Global Interventional Cardiology Devices Market Analysis & Forecast 2024-2034: Market By Product; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Peripheral Vascular Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite - Product Image

Global Peripheral Vascular Devices Market Size, Share & Trends Analysis 2024-2030 - MedSuite

  • Report
  • 1300 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.